Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Moderna, Inc. (MRNA) vs United Microelectronics Corp (UMC) Price & Performance

Moderna, Inc.Trade
United Microelectronics CorpTrade

Price performance (Past 24H)

Key statistics

Moderna, Inc. vs United Microelectronics Corp — how do they compare? Moderna, Inc. trades at $225 (market cap $78.65B), while United Microelectronics Corp trades at $22.96 (market cap $58.02B). The key difference: Moderna, Inc. is the larger of the two by market cap, and United Microelectronics Corp pays a 1.76% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Moderna, Inc. for 59 Days and United Microelectronics Corp for 42 Days on average.

MRNAUMC
Market Cap
$78.65B$58.02B
Volume
37,373,43711,897,809
Sector
HealthTechnology
52-Week High
$225.00$28.02
52-Week Low
$22.36$7.02
Typical Hold Time
59 Days42 Days
Enterprise Value
$74.80B$55.10B
Dividend Yield
—1.76%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Moderna, Inc.

Moderna (MRNA) trades at $197.00, up 0.26% today, reflecting a strong 2026 rally. The stock is technically bullish, with moving averages signaling strength and key support at $194. Fundamentally, revenue has declined from pandemic peaks to $1.92 billion in 2025, with net losses widening to -$2.82 billion, though recent quarters have beaten EPS estimates. The company's inclusion in the Nasdaq-100 index effective October 9, 2026, adds a positive catalyst. Analyst sentiment is mixed, with a consensus price target of $115.70 but a high target of $245.00, indicating divergent views on valuation after the stock's significant run-up.

The outlook for Moderna hinges on its pipeline beyond COVID-19, particularly cancer vaccines, but high valuation ratios (P/S of 35.08) and persistent losses pose risks. Upside potential exists if new products gain traction, yet investors face volatility from clinical trial outcomes and competitive pressures. The stock's proximity to 52-week highs suggests caution amid profit-taking signals from some analysts.

United Microelectronics Corp

UMC trades at $22.82, down 2.1% today but maintains strong fundamental momentum with three consecutive quarterly earnings beats. The stock shows bullish technical signals despite mixed moving averages, while fundamentals reveal robust profitability with 32.75% net income margin and improving cash flow trends. Recent news highlights analyst upgrades and strong AI-driven growth prospects.

Outlook remains positive with projected revenue growth to $250.7B in 2026 and intrinsic value estimates around $29 suggesting upside potential. Key risks include semiconductor cycle volatility and competitive pressures from larger foundries. Analyst consensus leans Hold but recent Strong Buy upgrades indicate growing optimism.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MRNA
53% Buy47% Sell
Avg holding period · 59 Days
UMC
59% Buy41% Sell
Avg holding period · 42 Days

Top news

Latest headlines on both assets

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

Read more on MRNA →

About United Microelectronics Corp

Founded in 1980, United Microelectronics is the world's third-largest dedicated chip foundry, with 7% market share in 2021, according to Gartner, after TSMC and GlobalFoundries. UMC's headquarters are in Hsinchu, Taiwan, and it operates 12 fabs in Taiwan, Mainland China, Japan and Singapore, with additional sales offices in Europe, the U.S. and South Korea. UMC features a diverse customer base including Texas Instruments, MediaTek, Qualcomm, Broadcom, Xilinx and Realtek, supplying a wide range of products applied in communications, display, memory, automotive and more. UMC employs about 20,000 people.

Read more on UMC →